Aashka HospitalsBOM:543346 78 EBITDA Margin % is 40.55% as of Mar. 2026, which is 22% above its 10-year median of 33.26. GuruFocus rates BOM:543346 with a GF Score™ of 78/100 and a GF Value™ of ₹91.34 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 664 Healthcare Providers & Services companies, Aashka Hospitals ranks better than 93.98% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Aashka Hospitals's EBITDA for the
six
months ended in Mar. 2026 was ₹51.0 Mil. Aashka Hospitals's Revenue for the
six
months ended in Mar. 2026 was ₹125.7 Mil. Therefore, Aashka Hospitals's EBITDA margin for the quarter that ended in Mar. 2026 was 40.55%.
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Aashka Hospitals EBITDA Margin % Related Terms
Aashka Hospitals EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Aashka Hospitals's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:543346 vs HCA, THC, DVA: EBITDA Margin % Comparison
For the Medical Care Facilities subindustry, Aashka Hospitals's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Aashka Hospitals EBITDA Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Aashka Hospitals's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Aashka Hospitals's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Aashka Hospitals (BOM:543346) has a EBITDA Margin % of 40.55% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Aashka Hospitals and its competitors. This is 22% above median its historical median of 33.26. Over the past decade, Aashka Hospitals' EBITDA Margin % has ranged from 17.65 to 37.71. According to the industry distribution chart, Aashka Hospitals ranks #40 out of 664 companies in the Healthcare Providers & Services industry, placing it in the top 6%.
Is Aashka Hospitals' EBITDA Margin % too high?
Aashka Hospitals' current EBITDA Margin % of 40.55% is 22% above median its 10-year median of 33.26. Over the past 10 years, this metric has ranged from a low of 17.65 to a high of 37.71. The Healthcare Providers & Services industry median EBITDA Margin % is 10.21. Aashka Hospitals' value of 40.55% is 297.2% above this industry median. Based on the distribution chart, Aashka Hospitals ranks #40 out of 664 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Aashka Hospitals has a GF Score™ of 78/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Aashka Hospitals' EBITDA Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Aashka Hospitals ranks #40 out of 664 companies for EBITDA Margin %. This places Aashka Hospitals in the top 6% of its industry — outperforming the majority of peers. The industry median EBITDA Margin % is 10.21. Aashka Hospitals' value of 40.55% is 297.2% above this benchmark. Historically, Aashka Hospitals' own EBITDA Margin % has ranged from 17.65 to 37.71 over the past decade. While the company's 10-year median is 33.26 vs. the industry median of 10.21, Aashka Hospitals has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.21, based on 664 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Aashka Hospitals's current EBITDA Margin % of 40.55% is 297.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Aashka Hospitals and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.21 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Aashka Hospitals's current EBITDA Margin % is 40.55%, which is 22% above median its own 10-year median of 33.26. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aashka Hospitals stock overvalued right now?
Based on GuruFocus' analysis, Aashka Hospitals (BOM:543346) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹91.34, compared to a current price of ₹81.25 — trading 11% below its estimated fair value. The current EBITDA Margin % is 40.55%, which is 22% above median its 10-year median of 33.26 and 297.2% above the Healthcare Providers & Services industry median of 10.21. Aashka Hospitals' overall GF Score™ is 78/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Aashka Hospitals (BOM:543346), the current EBITDA Margin % is 40.55% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Aashka Hospitals (BOM:543346) Overvalued in 2026?
Based on GuruFocus' analysis, Aashka Hospitals stock appears to be undervalued.
The current stock price of ₹81.25 is trading 11% below its estimated GF Value™ of ₹91.34.
GuruFocus considers Aashka Hospitals to be Modestly Undervalued.
Key valuation signals for BOM:543346:
EBITDA Margin %: 40.55% (22% above median its 10-year median of 33.26)
GF Value™: ₹91.34 vs. price of ₹81.25 (11% below fair value)
Industry Position: 297.2% above the Healthcare Providers & Services median (#40 of 664)
No single metric tells the full story. See the BOM:543346 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Aashka Hospitals Ltd is engaged in the operation of a Multi-Disciplinary Private Hospital, Clinics, and Pharmacies. The Main Business of the Company is to enhance the quality of life of patients by providing Comprehensive, Quality Hospital Services on a cost-effective basis. It serves a range of healthcare services such as Cardiology, neurology, neurosurgery, nephrology, anesthesiology, orthopedics, pediatric services, neonatology services, dermatology, radiology, dentistry, obstetrics, and gynecology, and more.
78GF Score
Get the complete analysis for BOM:543346
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:543346 has been successfully added to your 
